/Lists

Biotech Series B Investors & VC Firms

724 firms in this list, with a median first check of $500K. 165 of them lead rounds. Generated from verified public data and updated continuously.

Nextech Invest
ZurichSeed–Late Stage$648K – $3.2M
43 people
Artesian
SydneyPre-Seed–Growth$20M
41 people
Alexandria
PasadenaSeed–Series B
41 people
Hummingbird Ventures
BrusselsPre-Seed–Growth$500K – $10M
40 people
Samsara BioCapital
Menlo ParkSeed–Series C
42 people
Pitango
Tel AvivSeed–Growth$2M – $40M
39 people
Forbion
NaardenPre-Seed–Late Stage
25 people
Blume Ventures
MumbaiSeed–Series B$50K – $300K
34 people
Celesta Capital
San MateoPre-Seed–Series C$5M – $10M
26 people
XAnge
ParisPre-Seed–Series B$1.1M – $10.8M
22 people
Artis Ventures
San FranciscoSeed–Series B$50K – $25M
45 people
Seventure Partners
ParisSeed–Growth
19 people
Anzu Partners
BillericaPre-Seed–Series B
48 people
Basecamp Fund
ManchesterPre-Seed–Late Stage$100K – $10M
15 people
US Venture Partners
Menlo ParkSeed–Series C$500K – $10M
12 people
Hatteras Venture Partners
Research TriangleSeed–Series C$500K – $4M
23 people
Prime Movers Lab
JacksonSeed–Growth$2M – $30M
45 people
Sofina
BrusselsSeed–Late Stage$100M – $300M
57 people
HealthCap
StockholmSeed–Growth
33 people
Giant Ventures Global Llp
LondonPre-Seed–Growth$10M – $20M
32 people
Daphni
ParisSeed–Series B$540K – $6.5M
32 people
Granite Asia
SingaporeSeed–Late Stage$5M – $25M
35 people
Amadeus Capital Partners
LondonPre-Seed–Growth$50K – $12.7M
28 people
Abingworth
LondonSeed–Series C$15M – $30M
43 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.